MedPath

Assessment of Yoga asanas in patients with type 2 diabetes and NAFLD on quality of life.

Not Applicable
Conditions
Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications
Registration Number
CTRI/2024/03/064485
Lead Sponsor
Charu Paliwal
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

A man or woman 30-60 years old both inclusive who has been diagnosed with T2DM and NAFLD

Based on their medical history physical examination and laboratory tests participants must be medically stable

Participants must be capable of and willing to follow prohibitions and guidelines outlined in this protocol

Each participant must sign an informed consent form ICF attesting to their understanding of the studys goals and their willingness to take part in the study

Participant with fibroscan grading from 0 to 2

Participant with HbA1c between more than 7 to 10

Exclusion Criteria

A physical condition that significantly limits mobility wheelchair waking aid walking stick, cane or crutches)

Participant on insulin therapy

Trying to conceive or currently pregnant women or pregnant women with gestational diabetes

Highly uncontrolled diabetes HbA1c more than 10.0 percent

Evidence of other forms of liver disease apart from NAFLD or other chronic disease

Prior history of gastric bypass surgery or any other surgery

Recent start of any SGLT-2 inhibitor within 90 days of randomization or recent initiation or change of any anti-diabetic medication that affects liver fat

8.Participation in a weight loss/diet programme within 12 months of the screening or usage of prescription or over-the-counter weight-loss medication within 3 months of the screening

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the impact of yoga asanas, on QOL in patients of T2DM with NAFLD.Timepoint: At 3 months,6 Months, 9 Months and 12 months.
Secondary Outcome Measures
NameTimeMethod
To assess the impact of yoga asanas, on quality of life and biochemical parameters of diabetes (FBS, PPBS & HbA1c) and NAFLD (ALT & AST) <br/ ><br>Timepoint: Month 3,6,9 and 12;To assess the percentage of weight loss in patients withT2DM with NAFLDTimepoint: Month 3,6,9 and 12;To estimate the impact of Yoga asanas, on fibroscan in participants of NAFLD with diabetesTimepoint: Month 6 and 12
© Copyright 2025. All Rights Reserved by MedPath